Such beneficial effect was linked to the inhibition of KLK7 (Kallikrein-Related Peptidase 7) which is up-regulated in obesity-induced insulin resistance patients (Hida et al., 2005; Heiker et al., 2013). The gene discussed is KLK7; the disease is obesity due to melanocortin 4 receptor deficiency.